CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-19 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −2,604 | 9,896 | ||
| 2018-11-19 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −6,250 | 6,250 | ||
| 2018-11-19 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −3,262 | 9,238 | ||
| 2018-11-19 | Yoo Stephen Chief Medical Officer | Exercise or conversion | +20,414 | $0.85 | $17K | 20,414 |
| 2018-11-19 | Yoo Stephen Chief Medical Officer | Sale | −2,761 | $57.08 | $158K | 17,653 |
| 2018-11-19 | Yoo Stephen Chief Medical Officer | Sale | −2,300 | $58.37 | $134K | 15,353 |
| 2018-11-19 | Yoo Stephen Chief Medical Officer | Sale | −9,092 | $59.61 | $542K | 6,261 |
| 2018-11-19 | Yoo Stephen Chief Medical Officer | Sale | −4,361 | $60.25 | $263K | 1,900 |
| 2018-11-19 | Yoo Stephen Chief Medical Officer | Sale | −800 | $61.55 | $49K | 1,100 |
| 2018-11-19 | Yoo Stephen Chief Medical Officer | Sale | −1,100 | $63.21 | $70K | 0 |
| 2018-11-19 | Yoo Stephen Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −20,414 | 61,244 | ||
| 2018-11-16 | Simpson Curran SVP, Technical Operations | Exercise or conversion | +32,882 | $22.00 | $723K | 72,382 |
| 2018-11-16 | Simpson Curran SVP, Technical Operations | Sale | −4,000 | $61.91 | $248K | 68,382 |
| 2018-11-16 | Simpson Curran SVP, Technical Operations | Sale | −6,883 | $62.79 | $432K | 61,499 |
| 2018-11-16 | Simpson Curran SVP, Technical Operations | Sale | −6,505 | $63.64 | $414K | 54,994 |
| 2018-11-16 | Simpson Curran SVP, Technical Operations | Sale | −15,494 | $64.71 | $1.0M | 39,500 |
| 2018-11-16 | Simpson Curran SVP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −32,882 | 76,101 | ||
| 2018-11-15 | Vasista Vittal Chief Financial Officer | Sale | −2,170 | $58.46 | $127K | 135,113 |
| 2018-11-15 | Vasista Vittal Chief Financial Officer | Sale | −1,900 | $59.06 | $112K | 133,213 |
| 2018-11-15 | Vasista Vittal Chief Financial Officer | Sale | −588 | $60.40 | $36K | 132,625 |
Page 34 of 43 · 852 trades